This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets. New marketing authorisations Table 1 shows the new marketing authorisations for November 2021. TABLE 1: New marketing authorisations in November 2021 New Marketing Authorisations Product name and target species Active substance Authorisation Holder, territory, and distribution category Therapeutic group

As environmental issues come to the fore in the veterinary sector, President Elect Dave Rendle talks us through the challenges our profession faces and how BEVA aims to address them. Wind the clock back a few years and environmental issues never made the veterinary press. Now they are regularly front-page news and in the wake of COP26 the spotlight is firmly on sustainability in veterinary practice. The recent BVA policy statement on responsible use of parasiticides in cats and dogs is therefore

This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets. Novel actives Novocillin LC 1000 mg intramammary suspension for lactating cow This is the only authorised product containing oxacillin sodium. The product is indicated for treatment of clinical mastitis caused by Staphylococcus spp. (including β-lactamase producing strains) and Streptococcus spp. suscept